Researchers at the University of Washington have developed a technique to make saliva collection for diagnostic purposes a little less disgusting and a little more fun and pleasant. Saliva collection often acts as a…
Continue Reading
Healthcare generative AI is predicted to reach $22 billion by 2032, driven by strategic partnerships and AI solutions in drug discovery, diagnostics, and patient care. The Generative AI Tracker, a collaboration between Pymnts and…
Continue Reading
Lunit and Leeds Teaching Hospitals NHS Trust are launching the world’s first prospective study of AI-powered breast screening in symptomatic clinics, using Lunit INSIGHT MMG. This innovative initiative aims to improve breast cancer detection,…
Continue Reading
Blue Earth Diagnostics, a leading provider of PET radiopharmaceuticals, is set to present findings on POSLUMA (flotufolastat F 18) injection at the ASTRO 2023 Annual Meeting. POSLUMA aids in PET scans to detect prostate-specific…
Continue Reading
Theresa Hush, CEO and Co-founder of Roji Health Intelligence
Given Artificial Intelligence’s potential to improve patient care and reduce costs, it’s no surprise that AI applications are gaining momentum in health care. As your organization…
Continue Reading
Researchers at the University of Texas at Austin have developed an electroencephalogram (EEG) sensor that is incorporated into a virtual reality headset. The technology can measure brain activity while someone is undergoing an immersive…
Continue Reading
The following is a guest article by Morris Panner, President at Intelerad Medical Systems
By 2034, the U.S. could face a shortage of up to 124,000 physicians due, in part, to burnout. In the medical…
Led by 83North, This Round of Financing Brings Total Funding to Over $100 Million
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced it has closed a $55 million Series C financing round…
Lunit’s AI-powered solution, SCOPE IO, is transforming breast cancer care by improving the assessment of tumor-infiltrating lymphocytes (TILs). In a groundbreaking study, SCOPE IO demonstrated remarkable concordance with pathologists’ evaluations, reducing discordant cases significantly….
Continue Reading
A number of self-diagnostic tests have been launched into pharmacies, following a partnership between 2San and Phoenix Healthcare, which will help speed up diagnostics and allow consumers to take control of their health.The partnership…
Continue Reading
